Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting
- DOI
- 10.1186/s12919-021-00224-5
- Published
- 2021-08
- Container
- BMC Proceedings
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12919-021-00224-5,
title = {Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting},
author = {Shaheenah Dawood and Maria Konstantionva and Rebecca Dent and Florencia Perazzo and Sung-Bae Kim and Cynthia Villarreal-Garza and Sandra Franco and Ming-Shen Dai and Sergio Simon},
year = {2021},
journal = {BMC Proceedings},
doi = {10.1186/s12919-021-00224-5},
url = {https://doi.org/10.1186/s12919-021-00224-5}
}RIS
TY - JOUR TI - Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting AU - Shaheenah Dawood AU - Maria Konstantionva AU - Rebecca Dent AU - Florencia Perazzo AU - Sung-Bae Kim AU - Cynthia Villarreal-Garza AU - Sandra Franco AU - Ming-Shen Dai AU - Sergio Simon PY - 2021 JO - BMC Proceedings DO - 10.1186/s12919-021-00224-5 UR - https://doi.org/10.1186/s12919-021-00224-5 ER -
APA
Dawood, S., Konstantionva, M., Dent, R., Perazzo, F., Kim, S., Villarreal-Garza, C., Franco, S., Dai, M., & Simon, S. (2021). Optimizing treatment selection, and sequencing decisions for Management of HR-Positive, HER2-Negative advanced breast cancer – Proceedings from breast cancer expert group meeting. BMC Proceedings. https://doi.org/10.1186/s12919-021-00224-5
Source records
- crossref · retrieved 2026-09-26T12:05:47.490Z